278 Preclinical development of LYL119, a ROR1-targeted CAR T-cell product incorporating four novel T-cell reprogramming technologies to overcome barriers to effective cell therapy for solid tumors

278 Preclinical development of LYL119, a ROR1-targeted CAR T-cell product incorporating four novel T-cell reprogramming technologies to overcome barriers to effective cell therapy for solid tumors

Bibliographic Details
Main Authors: Rachel C Lynn, Purnima Sundar, Omar Ali, Christina Cheung, Shobha Potluri, Meritxell Galindo Casas, Candace Sims, Viola C Lam, Aileen Li, Jessica Barragan, Jessica Briones, Esha Afreen, Grant Vavra, Jia Lu, Rowena Martinez, Christina Ta, Eskedar Nigatu, Alexander S Cheung
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer
Description
ISSN:2051-1426

Similar Items